Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) Sees Large Increase in Short Interest

Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) was the target of a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 13,600 shares, an increase of 56.3% from the October 15th total of 8,700 shares. Approximately 0.4% of the shares of the stock are short sold. Based on an average daily trading volume, of 14,500 shares, the days-to-cover ratio is currently 0.9 days.

Cryo-Cell International Stock Performance

NYSEAMERICAN CCEL traded down $0.44 on Thursday, hitting $8.73. 25,426 shares of the stock were exchanged, compared to its average volume of 10,700. Cryo-Cell International has a 52-week low of $3.67 and a 52-week high of $9.50. The stock has a market cap of $70.36 million, a price-to-earnings ratio of -8.24 and a beta of 0.43.

Cryo-Cell International (NYSEAMERICAN:CCEL) last released its earnings results on Tuesday, October 15th. The company reported $0.13 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.02 by $0.11. Cryo-Cell International had a negative net margin of 28.03% and a negative return on equity of 42.06%. The company had revenue of $8.07 million during the quarter.

Cryo-Cell International Dividend Announcement

The firm also recently announced a — dividend, which will be paid on Friday, November 29th. Shareholders of record on Friday, November 15th will be given a $0.25 dividend. The ex-dividend date is Friday, November 15th.

Cryo-Cell International Company Profile

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.